12 Week Efficacy of Tiotropium Versus Placebo in Patients With Mild COPD According to Swedish Guidelines (SPIRIMILD)
Status:
Completed
Trial end date:
2005-07-01
Target enrollment:
Participant gender:
Summary
To show that treatment with tiotropium inhalation capsules (18 μg q.d.) via HandiHaler®
improves lung function in patients with mild COPD according to Swedish guidelines.